LED (lncRNA activator of enhancer domains) and FAL1 (focally amplified lncRNA on chromosome 1) lncRNAs are able to specifically control the expression of CDKN1A gene, even though through different mechanisms, and their deregulation in cancer accounts for the loss of p21 activation. The gene discussed is CDKN1A; the disease is cancer.